Inventing Disease And Pushing Pills
Download Inventing Disease And Pushing Pills full books in PDF, epub, and Kindle. Read online free Inventing Disease And Pushing Pills ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Jörg Blech |
Publisher | : Taylor & Francis |
Total Pages | : 148 |
Release | : 2023-05-09 |
Genre | : Medical |
ISBN | : 1000938573 |
This is a highly accessible and reassuring account of how the pharmaceutical industry is redefining health, making it a state that is almost impossible to achieve. Many normal life processes – states as natural as birth, ageing, sexuality, unhappiness and death – are systematically being reinterpreted as pathological so creating new markets for their treatments. In this enlightening book, Jörg Blech reveals: how the invention of diseases by pharmaceutical companies is turning us all into patients, and how we can protect ourselves against this how the medical profession has been bullied and co-opted into endorsing profitable cures for people who aren't ill fears about how pharmaceutical companies create markets by playing on the general public's concern with their health A self-help book in the truest sense, Inventing Disease and Pushing Pills reassures us about our own health. It is essential reading for doctors, nurses and patients alike.
Author | : Jorg Blech |
Publisher | : Da Capo Lifelong Books |
Total Pages | : 258 |
Release | : 2009-03-24 |
Genre | : Health & Fitness |
ISBN | : 0786752173 |
In Healing Through Exercise, internationally bestselling science writer Jörg Blech sets out the actual physiological effects of exercise: it triggers the growth of new brain cells, induces stem cells in blood vessels, and reverses symptoms of heart disease and type 2 diabetes. Doctors are now using exercise to combat common ailments such as heart disease, arthritis, diabetes, osteoporosis, and depression. Every one of us—whether a healthy athlete, a patient seeking to overcome a chronic disease, or a person desiring a longer, more mentally active life—can use the new and important information in this book.
Author | : Tullio Giraldi |
Publisher | : Springer |
Total Pages | : 206 |
Release | : 2017-08-08 |
Genre | : Psychology |
ISBN | : 3319576577 |
This book examines existing treatments, legislation and research methodology of depression and exposes their limitations, championing psycho-social support as an alternative. Depression, affecting 350 million people according to the World Health Organisation, is almost invariably diagnosed by the criteria of the American Psychiatric Association – a definition which encompasses those with normal emotional responses to stressful life events. Tullio Giraldi discusses recent developments in popular and academic dialogue related to the use of antidepressants and recent increases in depression diagnosis and laments the rise in prescribing antidepressants despite their links to suicide and unfulfilled promises of efficacy and safety. He argues that psychotherapy is a cost effective treatment devoid of drugs' adverse effects. This work presents psycho-social support as an alternative to antidepressants, particularly for less severe cases, and as a more effective strategy for coping with the emotional challenges of today’s global reality. Patients, students of medicine and psychology, and professionals of mental health will find this work valuable.
Author | : Ray Moynihan |
Publisher | : Greystone Books |
Total Pages | : 171 |
Release | : 2008-09-01 |
Genre | : Health & Fitness |
ISBN | : 1926706684 |
In this hard-hitting indictment of the pharmaceutical industry, Ray Moynihan and Allan Cassels show how drug companies are systematically using their dominating influence in the world of medical science, drug companies are working to widen the very boundaries that define illness. Mild problems are redefined as serious illness, and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. Selling Sickness reveals how expanding the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt national healthcare systems all over the world. This Canadian edition includes an introduction placing the issue in a Canadian context and describing why Canadians should be concerned about the problem.
Author | : Martyn Pickersgill |
Publisher | : Emerald Group Publishing |
Total Pages | : 347 |
Release | : 2012-07-30 |
Genre | : Social Science |
ISBN | : 1780526326 |
The neurosciences are more than a collection of scientific practices - they offer up various ways of thinking about mind, body and society. This title casts light on the place, role and impact of neuroscience. It reflects on the insights the neurosciences have to offer sociology.
Author | : Suzanne Taylor |
Publisher | : McGill-Queen's Press - MQUP |
Total Pages | : 207 |
Release | : 2022-10-31 |
Genre | : Medical |
ISBN | : 022801350X |
When cannabis tincture was withdrawn from the medical establishment in the UK in 1973, cannabis became regulated solely as an illicit drug. Within a decade cannabis-based drugs were back in the clinic. The UK is one of the biggest producers of medicinal cannabis, but few patients have access to these medicines. High-profile cases of parents campaigning for access to cannabis oil for severe and rare forms of epilepsy in their children are the most recent in a long line of controversies over cannabis and cannabis-based medicines. With mounting questions about patient access, the effectiveness of international drug control systems, and the role of expert advice, it is crucial to understand how we have arrived at this situation. While the historical literature has focused on cannabis as an illicit substance, Remedicalizing Cannabis considers the botanical product and its potential to yield medical applications. Investigating the remedicalization of cannabis, Taylor explores the process whereby boundaries shift between illicit drug and licit medicine. Basing her arguments on archival material from expert committees, researchers, and activists and in-depth interviews with key players, Suzanne Taylor traces the issues and interests involved in this process, demonstrating the important roles of changing scientific knowledge, expert advice, industry, clinical trials, and patient activism. Remedicalizing Cannabis investigates the evolving tensions that have brought us to the current situation and demonstrates the role of history in understanding today’s debates about cannabis.
Author | : Charles Krinsky |
Publisher | : Routledge |
Total Pages | : 318 |
Release | : 2016-12-05 |
Genre | : Social Science |
ISBN | : 1351916785 |
The concept of moral panic has received considerable scholarly attention, but as yet little attention has been accorded to panics over children and youth. This is the first book to examine this important and controversial social issue by employing a rigorous intellectual framework to explore the cultural construction of youth, through the dissemination of moral panics. It is accessible in manner and makes use of the latest contemporary research by addressing some of the pressing recent concerns relating to children and youth, including cyber-related panics, child abuse and pornography, education and crime. A truly international collection, this volume features new global research focusing on the United Kingdom, Australia, Canada, South Africa, and France as well as the United States. Genuinely multidisciplinary in approach, it will appeal to researchers and students across the social sciences and humanities - from sociology and social theory, to media, education, anthropology, criminology, geography and history.
Author | : Fernando De Maio |
Publisher | : Bloomsbury Publishing |
Total Pages | : 200 |
Release | : 2014-05-01 |
Genre | : Social Science |
ISBN | : 1137400633 |
Despite living in a 'globalized' world where advances in medicine, technology and science come at an ever-increasing pace, there exist staggering inequalities in health. Even as we celebrate new pharmaceutical developments, access to already-existing medicines is hindered by economic and political barriers for poor people around the world. Critical but accessible, Global Health Inequities questions taken-for-granted assumptions, showing how breakthroughs in biomedicine alone cannot address inequities in health. The book's analysis of theory and empirical work elucidates key debates and highlights the most significant challenges facing global health today, including the growing burden of chronic non-communicable diseases and the persistent injustice of neglected tropical diseases. Fernando De Maio identifies the need for sociological analysis in global health, drawing together research from public health, sociology, anthropology and related fields, in order to expand the scope of the medical gaze towards a more holistic and structural perspective of health inequity.
Author | : P. Malhotra |
Publisher | : Springer |
Total Pages | : 337 |
Release | : 2010-10-13 |
Genre | : Business & Economics |
ISBN | : 0230290744 |
In India today only 35 percent of people have access to medicines. This book examines the rise of drug prices in India, and develops a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable
Author | : Ajay Bhaskarabhatla |
Publisher | : Springer |
Total Pages | : 304 |
Release | : 2018-08-01 |
Genre | : Business & Economics |
ISBN | : 3319933930 |
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible. The book draws on extensive empirical research involving India’s 2013 Drug Price Control Order and widely-used medicines such as paracetamol and metformin to illustrate how firms have weakened regulation. It argues that the regulatory regime can be strengthened by using systematic analysis of product- and region-level data in the Indian pharmaceutical industry, and by screening for the strategies that firms currently employ to circumvent regulation. In closing, it discusses recent efforts to strengthen the implementation of price controls in India and expanding the scope of price controls to medical devices.